These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7908924)

  • 1. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children.
    Spencer LT; Ogino MT; Dankner WM; Spector SA
    J Infect Dis; 1994 Mar; 169(3):491-5. PubMed ID: 7908924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.
    Kozal MJ; Shafer RW; Winters MA; Katzenstein DA; Aguiniga E; Halpern J; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):832-8. PubMed ID: 7517448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the HIV-1 syncytium-inducing phenotype on disease stage in vertically-infected children.
    Fitzgibbon JE; Gaur S; Gavai M; Gregory P; Frenkel LD; John JF
    J Med Virol; 1998 May; 55(1):56-63. PubMed ID: 9580887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.
    Richman DD; Bozzette SA
    J Infect Dis; 1994 May; 169(5):968-74. PubMed ID: 7909549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.
    Boucher CA; Lange JM; Miedema FF; Weverling GJ; Koot M; Mulder JW; Goudsmit J; Kellam P; Larder BA; Tersmette M
    AIDS; 1992 Nov; 6(11):1259-64. PubMed ID: 1282015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Koot M; Keet IP; Vos AH; de Goede RE; Roos MT; Coutinho RA; Miedema F; Schellekens PT; Tersmette M
    Ann Intern Med; 1993 May; 118(9):681-8. PubMed ID: 8096374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.
    Roos MT; Lange JM; de Goede RE; Coutinho RA; Schellekens PT; Miedema F; Tersmette M
    J Infect Dis; 1992 Mar; 165(3):427-32. PubMed ID: 1347054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.
    Forte SE; Byron KS; Sullivan JL; Somasundaran M
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1613-8. PubMed ID: 7888220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1.
    Connor RI; Paxton WA; Sheridan KE; Koup RA
    J Virol; 1996 Dec; 70(12):8758-64. PubMed ID: 8971004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity and diversity of HIV and implications for clinical management: a review.
    Saag MS; Hammer SM; Lange JM
    J Acquir Immune Defic Syndr (1988); 1994; 7 Suppl 2():S2-10; discussion S10-1. PubMed ID: 7965648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 phenotypes in children with advanced disease treated with long-term zalcitabine.
    Viani RM; Smith IL; Spector SA
    J Infect Dis; 1998 Mar; 177(3):565-70. PubMed ID: 9498433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.
    van't Wout AB; Ran LJ; de Jong MD; Bakker M; van Leeuwen R; Notermans DW; Loeliger AE; de Wolf F; Danner SA; Reiss P; Boucher CA; Lange JM; Schuitemaker H
    J Clin Invest; 1997 Nov; 100(9):2325-32. PubMed ID: 9410911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
    Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of different HIV-1 phenotypic subpopulations through the natural history of the infection].
    Pérez Alvarez L; Verdejo J; González Lahoz J; Gurbindo D; Hernández-Sampelayo T; Moreno E; Azañedo M; Contreras G; Medrano L; Nájera R
    Med Clin (Barc); 1998 Apr; 110(12):441-5. PubMed ID: 9611711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of HIV isolates in primary HIV infection: consequences for the subsequent course of infection.
    Nielsen C; Pedersen C; Lundgren JD; Gerstoft J
    AIDS; 1993 Aug; 7(8):1035-40. PubMed ID: 8104421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High IL-7 plasma levels may induce and predict the emergence of HIV-1 virulent strains in pediatric infection.
    Kopka J; Mecikovsky D; Aulicino PC; Mangano AM; Rocco CA; Bologna R; Sen L
    J Clin Virol; 2005 Jul; 33(3):237-42. PubMed ID: 15911446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study Group.
    St Clair MH; Hartigan PM; Andrews JC; Vavro CL; Simberkoff MS; Hamilton JD
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):891-7. PubMed ID: 8315574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.